Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
Holding SYRE?
Track your performance easily

Spyre Therapeutics (SYRE) Balance Sheet

419 Followers

Spyre Therapeutics Balance Sheet

Spyre Therapeutics's total assets for Q2 2024 were $436.07M, a decrease of -10.57% from the previous quarter. SYRE total liabilities were $51.11M for the fiscal quarter, a -84.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 341.86M$ 71.14M$ 109.93M$ 161.62M$ 83.18M
Total Liabilities
$ 73.29M$ 20.84M$ 25.98M$ 21.79M$ 23.10M
Total Equity Gross Minority
$ 184.02M$ 50.33M$ 83.94M$ 139.83M$ 60.08M
Total Capitalization
$ 184.02M$ 50.30M$ 83.94M$ 139.83M$ 60.08M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 5.45M$ 5.06M
Currency in USD

Spyre Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis